Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Biofiller versus connective tissue graft to thicken lower front gums

Official title: Evaluation of the Effectiveness of Blood Concentrate Biofiller in Thickening the Gingival Phenotype Around Natural Teeth

Run by Inonu University · NCT07104019 · Data updated 2026-11-12

This trial will test whether a new autologous gel called Biofiller or the standard connective tissue graft better thickens thin gums in adults with thin lower front teeth.

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment34 (estimated)
SponsorInonu University
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Malatya)
StatusRecruiting
StartedJuly 30, 2025
Main results expectedNovember 3, 2025
Study endsMay 1, 2026
Registry record updatedAugust 12, 2025
Trial IDNCT07104019 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are systemically healthy adults aged 18–60, non-smokers, not pregnant or breastfeeding, with a thin gingival phenotype in the lower front (canine-to-canine) region and no medications or conditions that impair wound healing.

Probably not a fit

Patients with systemic diseases, smokers, poor oral hygiene, prior radiotherapy/chemotherapy, complex orthodontic anomalies, or a thick gingival phenotype are unlikely to benefit from this specific comparison.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized controlled trial comparing Biofiller (an autologous gel made from heated platelet-poor plasma combined with concentrated platelet-rich fibrin) to the standard connective tissue graft for increasing gingival thickness in the mandibular anterior region. Thirty-four systemically healthy, non-smoking adults with a thin gingival phenotype will be randomized and all will receive a standardized tunneling procedure from canine to canine. Outcomes will focus on changes in gingival thickness and keratinized tissue using clinical and imaging measurements at baseline and follow-up. The study aims to determine whether Biofiller can offer comparable tissue thickening with less donor-site morbidity than autogenous grafting.

Why it matters

Potential benefit: If successful, Biofiller could provide a less invasive way to thicken thin gums while avoiding a second surgical donor site and improving patient comfort.

How similar studies have gone: Connective tissue grafting is an established method to increase gingival thickness, while platelet-rich fibrin and other autologous platelet-derived materials have shown promising but limited evidence, and Biofiller itself is a novel formulation with limited published data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age between 18 and 60 years
* Systemically healthy individuals
* Presence of thin gingival phenotype in the mandibular anterior region (canine to canine)
* No medications that affect wound healing
* No history of bleeding disorders
* No known allergy to anti-inflammatory drugs
* Not pregnant or breastfeeding
* Willingness to participate and provide informed consent
* Non-smoker

Exclusion Criteria:

* Systemic diseases (e.g., diabetes, hypertension, cancer, etc.)
* Use of medications that may affect healing (e.g., corticosteroids, immunosuppressants)
* History of radiotherapy or chemotherapy
* Pregnancy or breastfeeding
* Poor oral hygiene
* Refusal to participate
* Age under 18 years
* Smoking
* Presence of Class II or Class III orthodontic anomalies

Where it's running

  • Inonu university
    Malatya, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.